31 
sion, such as correspondence, etc., as well as gathering information and 
preliminary analysis of many of the issues. 
It is likely that there will he times when the Commission will require 
very specific knowledge or analyses which are outside the expertise of 
any of the Commissioners of staff members. Thus, the use of technical 
experts and consultants would be expected to be essential to the proper 
functioning of the Commission. 
SECTION 202. DUTIES OF THE COMMISSION 
Paragraph (1) directs the Commission to conduct a study of Federal 
policy regarding activities regarding genetic manipulation or orga- 
nisms and viruses including consideration of the interim controls 
described in title I of this act, the effect of non-Federal requirements 
and the need for Federal preemption, federally sponsored risk assess- 
ment studies and the progress of federally sponsored basic and applied 
research. 
Paragraph (2) requires the Commission to assess the long term con- 
sequences of the development of a technology capable of the geqetic 
modification of organisms and viruses, including the anticipated med- 
ical and commercial applications, and the ethical, moral, social, eco- 
nomic and political implications of the development and use of such 
technology. 
SECTION 203. HEARING AUTHORITY, COOPERATION ET OTHER FEDERAL 
AGENCIES AND THE DISCLOSURE OF CONFIDENTIAL DATA 
203(a). The Commission shall hold public hearings as appropriate 
to assist it in carrying out its functions under sections 202 and 203. 
203(1)). Cooperation by other Federal agencies 
The Commission is empowered to secure information from any 
Federal agency to enable it to carry out its duties. The head of any 
such department or agency shall furnish such information upon re- 
quest. 
203(c). Disclosure of data 
The disclosure of any confidential information obtained by the Com- 
mission is governed by section 480, of title I of the Kecombinant DNA 
Act. 
SECTION 204. COMMISSION REPORTS AND TERMINATION OF THE 
COMMISSION 
20 4- (a). Preliminary report 
Within 18 months of the date of enactment, the Commission must 
report to Congress the preliminary results of the evaluation prescribed 
by paragraph (1) of section 202. This requirement is to assist Con- 
gress in determining whether or not to extend Title I of this Act 
beyond two years, and, if so, what changes might be needed. 
205(b). Final report 
The Commission must complete the studies prescribed by section 202 
and, on the basis of its findings, make recommendations to the Con- 
H. Rept. 95-1005 5 
[Appendix B — 161] 
